Further investigation unraveled the role of miR-98-related cisplatin resistance and mitochondrial dynamics, demonstrating that ectopic miR-98 was able to promote mitochondrial fragmentation in cancer cells, with the upregulation of active Drp1 and its receptor Fis1, and increase in mitochondrial membrane potential, resulting in chemotherapy resistance. Here, DNM1L is linked to cancer.